Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...

Efficacy is higher for the Xen 45 gel stent implant as a standalone procedure than combined with cataract surgery. The Xen 45 gel stent implant provides effective, long-term treatment for open-angle ...

FDA has announced it has approved the first glaucoma stent for use with cataract surgery, according to a news release. The iStent Trabecular Micro-Bypass Stent System, model GTS100R/L, manufactured by ...

New minimally invasive glaucoma treatments, including stents placed during cataract surgery and long-acting eye implants, are now available in Cape May County, reducing reliance on daily eye drops.

The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma. The stent, produced by Fort Worth, Texas-based Alcon, is a micro-invasive surgical device used ...

Christine Funke, MD, a glaucoma specialist at Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, discussed how minimally invasive glaucoma surgery (MIGS) has been able to offer her patients better ...

ZURICH, Aug 29 (Reuters) - Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically ...

CHERRY HILL, N.J. (WPVI) -- A new procedure is helping to preserve vision for some people with glaucoma. Glaucoma is a silent thief, affecting 3 million Americans, slowly robbing them of their sight.

Glaucoma is a group of eye diseases that cause slow, progressive damage to the optic nerve in the back of the eye, says Schultz. This growing damage is due to unsafe fluid buildup that causes pressure ...